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Outcome of long-axis percutaneous
sacroplasty for the treatment of sacral
insufficiency fractures
Abstract Our aim was to assess the
clinical outcome of patients who were
subjected to long-axis sacroplasty for
the treatment of sacral insufficiency
fractures. Nineteen patients with uni-
lateral (n=3) or bilateral (n=16) sacral
fractures were involved. Under local
anaesthesia, each patient was sub-
jected to CT-guided sacroplasty using
the long-axis approach through a sin-
gle entry point. An average of 6 ml of
polymethylmethacrylate (PMMA)
was delivered along the path of each
sacral fracture. For each individual
patient, the Visual Analogue pain
Scale (VAS) before sacroplasty and at
1, 4, 24 and 48 weeks after the
procedure was obtained. Furthermore,
the use of analgesics (narcotic/non-
narcotic) along with the evolution of
post-interventional patient mobility
before and after sacroplasty was also
recorded. The mean pre-procedure
VAS was 8±1.9 (range, 2 to 10). This
rapidly and significantly (P<0.001)
declined in the first week after the
procedure (mean 4±1.4; range, 1 to 7)
followed by a gradual and significant
(P<0.001) decrease along the rest of
the follow-up period at 4 weeks (mean
3±1.1; range, 1 to 5), 24 weeks (mean
2.2±1.1; range, 1 to 5) and 48 weeks
(mean 1.6±1.1; range, 1 to 5). Eleven
(58%) patients were under narcotic
analgesia before sacroplasty, whereas
8 (42%) patients were using non-
narcotics. Corresponding values after
the procedure were 2/19 (10%; nar-
cotic, one of them was on reserve) and
10/19 (53%; non-narcotic). The re-
maining 7 (37%) patients did not
address post-procedure analgesic use.
The evolution of post-interventional
mobility was favourable in the study
group as they revealed a significant
improvement in their mobility point
scale (P<0.001). Long-axis percuta-
neous sacroplasty is a suitable, mini-
mally invasive treatment option for
patients who present with sacral in-
sufficiency fractures. More studies
with larger patient numbers are needed
to explore any unrecognised limita-
tions of this therapeutic approach.
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Introduction
Sacral insufficiency fracture is a common clinical problem
in elderly osteoporotic individuals. This debilitating patho-
logical condition may subject the patients to the known
complications of long-term immobilisation like respiratory
and urinary tract infections, bed sores and deep venous
thrombosis with or without subsequent pulmonary embo-
lism [1]. Treatment of sacral insufficiency fractures is
primarily based upon bed rest along with analgesic
coverage and physical therapy/rehabilitation as soon as
tolerated. This conservative approach, however, is known
to be time-consuming, as several months must have
elapsed before obtaining significant recovery [2]. Further-
more, pre-existing osteoporosis may progress secondary to
such a relatively long period of inactivity. Percutaneous
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placement of iliosacral screws is a relatively newminimally
invasive alternative [2–5]. It is noteworthy, however, that
besides the recorded technical difficulty of this approach,
stable sacroiliac osteosynthesis may not be fully achieved in
bone chronically weakened by osteoporosis [5].
With the successful introduction of cement augmenta-
tion of cancellous bone in the treatment of osteoporotic
vertebral compression fractures, there has been rising
interest in applying the same concept to treat sacral
insufficiency fractures [6–9]. Currently, there are some
encouraging reports on the favourable outcome of patients
subjected to short-axis sacroplasty. As we have previously
introduced the advantageous CT-guided long-axis ap-
proach that reduces the number of needles used and
provides precision, safety and speed [9], we were interested
in resuming our experience, along with the clinical
outcome of the first cohort of patients treated with this
new technique.
Materials and methods
Institutional review board approval was obtained for the
present analysis, which included 19 patients (16 women
and 3 men; mean age, 78 years; age range, 58 to 97 years)
who were treated with percutaneous sacroplasty for sacral
insufficiency fractures. In our institute, all patients must
give their written informed consent after having the
procedures explained to them. Using the long-axis ap-
proach, as previously described by Binaghi et al. [9],
standard prone positioning of the patients in the CT unit
under conscious sedation with midazolam was chosen. CT
data were obtained with an eight-row CT unit (Lightspeed
Ultra; GE Medical Systems, Milwaukee, WI). The area to
be treated was prepared in a strictly sterile manner, and then
local anaesthesia was applied. The first part of the CT
guidance dedicated to the placement of the needle is set in
incremental mode, with the tilting of the CT gantry in a
plane as parallel as possible to that of the body of the
sacrum, in order to visualise the complete intraosseous path
along which the needle has to be advanced. When needed,
some specific positioning pillows were placed under the
patient’s thighs or knees to adjust the vertical position of
the sacral bone in order to fit the tilting limits of the CT
gantry. After a small skin incision, an 11-gauge beveled
vertebroplasty needle (OsteoSite Bone Biopsy Needle Set,
Cook, Bjaeverskov, Denmark) was positioned at the entry
point to the sacrum. Then, the needle was inclined, directed
and advanced according to the laser alignment light of the
CT unit in order to achieve precise control of the access
between the sacroiliac joints and the sacral foramina, going
from the inferior aspect to the superior aspect of the
fracture. Accordingly, complete visualisation of the needle
on the same CT slice could be achieved until its final
destination. The successive injection of polymethylmetha-
crylate (PMMA, Vertebroplastic, DePuy Acromed Inc.,
Raynham, MA) was performed under helical CT control,
with the CT gantry in a vertical position. Two 10-ml high-
pressure injector sets (OsteoForce, Cook, Bjaeverskov,
Denmark) were simultaneously used by two operators on
both sides of the fracture for the injection of PMMA. An
average of 6 ml of PMMAwas delivered on each side of the
fracture; the injection was carried out very slowly with
constant checking for any cement leakage towards the
sacral foramina or the sacroiliac joints. If leakage was
going to appear, the bevel of the needle had to be
immediately directed to the opposite direction of the
leakage or the needle had to be withdrawn slightly. During
PMMA administration, the needles were progressively
withdrawn from the first sacral level towards the entry
point located on the third or fourth sacral level, under
intermittent observation by successive helical CT series, in
order to fill the entire length of the fracture.
To obtain the follow-up data, all subjects were first
contacted by telephone to obtain their oral agreement to
participation after explaining the aim of the study. In the
case of agreement, each patient was required to score his
pain (1, none; 10, worst) before and after sacroplasty (at 1,
4, 24 and 48 weeks) using the Visual Analogue Scale
(VAS). Using a 5-point scale (1 normal, no pain; 2 normal
with pain; 3, limited, with pain; 4, wheel chair; 5,
bedridden) all patients were asked about the evolution of
their post-interventional mobility. Furthermore, the use of
analgesics (narcotic/non-narcotic) after discharge until the
day of interrogation was also recorded. The pre-sacroplasty
state of mobility and analgesic use were both obtained from
the inpatient hospital charts of each individual subject. The
telephone interview was then terminated by a question
about the general post-procedure satisfaction. Besides any
potential treatment failure, peri-procedural complications
like penetration of the sacral cortex, haemorrhage or
cement extrusion into the sacral neuroforamina were
recorded.
0
1
2
3
4
5
6
7
8
9
Baseline* 1w* 4w* 24w* 48w*
VAS Pain Score
(mean values)
Fig. 1 Plot shows the evolution of the VAS pain score in the study
cohort throughout a follow-up period of 48 weeks. *P<0.001, 95%
confidence interval of VAS values at baseline, 1 week, 4 weeks,
24 weeks and 48 weeks were 7.03–8.96, 3.29–4.70, 2.43–3.56,
1.64–2.80 and 1.10–2.23, respectively
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Results
The most likely provocative factors for sacral insufficiency
fracture in our series were osteoporosis (n=17) and post-
radiotherapy osteopenia (n=2). Sixteen patients had bilat-
eral sacral alar fractures and underwent percutaneous
sacroplasty on either side, whereas three patients had
unilateral fractures. Among the entire study population, 18
(95%) patients were available at all follow-up intervals,
whereas 1 patient died 4 months after the procedure of
unrelated causes. The mean pre-procedure VAS score was
8±1.9 (range, 2 to 10). This rapidly and significantly (P<
0.001, ANOVA analysis) declined in the first week after the
procedure (mean 4±1.4, range, 1 to 7) followed by a
gradual but still significant (P<0.001, ANOVA analysis)
decrease throughout the rest of the follow-up period at
4 weeks (mean 3±1.1, range, 1 to 5), 24 weeks (mean 2.2±
1.1, range, 1 to 5) and 48 weeks (mean 1.6±1.1, range, 1 to
5) (Fig. 1). Eleven (58%) patients were under narcotic
analgesia before sacroplasty, whereas eight (42%) patients
were using non-narcotics (Fig. 2). Corresponding values
after the procedure were 2/19 (10%) (narcotic, one of them
was on reserve) and 10/19 (53%) (non-narcotic). The
remaining 7 (37%) patients did not address post-procedure
analgesic use as shown in Fig. 2. The evolution of post-
interventional mobility was favourable in the study group
as they revealed a significant improvement in their mobility
point scale (pre-procedure mean value, 4.3±1; range, 3 to 5
vs. 2.3±1.2; range, 1 to 5 for post-procedure, P<0.001,
paired t test). It is worth noting that 11 (58%) patients
revealed a full return to normal mobility (Fig. 3).
Fifteen (79%) patients were generally satisfied with their
treatment and recorded a significant improvement in their
lifestyle (Fig. 4). On the other hand, four patients with
persisting sacralgia (n=1) and low backache (n=3) were
not generally satisfied. The origin of sacralgia in the first
patient was inadequate cement distribution along the
transverse component of an oblique sacral fracture
(Fig. 5). In the other three patients with persisting low
backache, despite adequate and homogeneous cement
distribution along the sacral fracture lines, two had non-
consolidating fractures of the transverse processes of the
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Fig. 2 Two plots show the distribution of analgesic use in the study
cohort (a) before and (b) after sacroplasty
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Fig. 3 Two plots show the evolution of post-interventional mobility
in the study cohort (a) before and (b) after sacroplasty (*because of
general weakness and equilibrium disturbances)
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fifth lumbar vertebra and of the iliac bone, whereas the
third was known to have an untreated lower lumbar disc
herniation. During the hospitalisation period, no major
complications were encountered, and most patients could
be discharged within 24 h of the procedure.
Discussion
The incidence of sacral insufficiency fracture is increasing
within the rapidly growing population of elderly people
where osteoporosis prevails. Other, less frequent risk
factors include rheumatoid arthritis, prolonged corticoste-
roid treatment and pelvic irradiation [10]. Given that the
overall 1-year mortality rate associated with pelvic insuf-
ficiency fractures is ~14% [11], every effort must be made
to diagnose early and efficiently treat this pathological
condition. Unlike the well-established clinical benefit of
percutaneous vertebroplasty, sacroplasty does not represent
the standard care for patients who present with sacral
insufficiency fracture. This is primarily related to the
obvious lack of studies that consider its outcome and safety
profile. In the present report, we observed a dramatic
response to this therapeutic option in almost all patients
with sacral insufficiency fracture. In fact, most patients
addressed a significant reduction in their pain score along
with remarkable improvement in their daily mobility
(Figs. 1, 2 and 3). This is not surprising as the consolidating
effect of the PMMA has the potential to reduce or even
suppress the motion within the fracture line that provokes
pain through stimulating the periosteal nerve endings along
the fracture interface. Second, its thermogenic effect has
been claimed to be somewhat analgesic and is thought to be
the main contributor to short-term pain relief [10].
Since the first report on sacroplasty for the treatment of
sacral insufficiency fractures was published, five dedicated
studies have evaluated the clinical outcomes of 120
patients who were subjected to this new treatment approach
[1, 12–15]. These studies invariably reported rapid and
substantial pain relief, which led to significant improve-
ment in the overall quality of life. Our results lend support
to these findings; it has to be noted, however, that some
Fig. 4 CT of a 76-year-old female patient with bilateral sacral
fractures successfully treated with long-axis sacroplasty (a and b)
shows adequate and homogeneous cement distribution on both sides
(c)
a
b
Fig. 5 CT of a 62-year-old male patient with persisting sacralgia
after treatment shows lack of cement filling in the transverse
component of his fracture (arrows in a and b)
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complications like transient radiculitis and cement extra-
vasation into the central canal, sacral foramina or sacroiliac
joint were previously encountered. These events could be
efficiently contained by immediate measures to minimise
the propagation of any hazardous effect. In our series,
however, we did not observe any of the aforementioned
complications, potentially because of applying the CT-
guided long-axis approach, which facilitates cement deliv-
ery along the fracture line using a single entry point.
Furthermore, this approach allows better determination of
the needle depth and trajectory into the sacral mass and
consequently facilitates its manipulation during the proce-
dure. We believe that the CT-guided long-axis sacroplasty
is advantageous over the same fluoroscopy-guided ap-
proach, especially in avoiding the risk of penetrating the
cephalad cortex of the S1 sacral ala that usually leads to
cement extrusion into the adjacent soft tissues [16].
Additionally, its application in obese patients may also
facilitate the procedures and reduce the overall time
required for cement installation. It has to be recognised,
however, that real-time monitoring of cement installation
using fluoroscopy is a vital advantage that is not currently
provided by the CT-guided approach. Whether long-axis
sacroplasty is also feasible for traumatic, non-displaced
sacral fractures in patients with senile osteoporosis needs to
be established.
Incomplete treatment success in the form of persisting
sacralgia was observed in 1/19 patients (0.5%) in the
present series. The reason why sacroplasty failed in this
patient was inadequate cement distribution along the
transverse component of an oblique sacral fracture
(Fig. 5). This may imply that for sacral fractures with
mixed longitudinal and transverse components, a tradi-
tional short-axis sacroplasty should be taken into con-
sideration besides the long-axis approach. Three patients
with successfully treated unilateral (n=1) and bilateral
(n=2) sacral fractures addressed persisting low backache
after the procedure. In fact, two of these three patients had
non-consolidating fractures of the transverse processes of
the fifth lumbar vertebra and of the iliac bone, respectively.
We believe that these unhealed fractures were responsible
for the patients’ symptomatology as they had adequate and
homogeneous cement distribution along their sacral frac-
ture lines. The third patient was known to have an untreated
disc hernia of the lower lumbar segment.
A limitation of the present study is its low number of
patients (n=19). Despite this fact, our series still represents
the largest one yet published that selectively presents the
outcome of patients subjected to the long-axis sacroplasty
approach. A second limitation is that we did not randomise
a control group with a conservative treatment algorithm in
our study design. It has to be recognised, however, that the
remarkable improvement in the post-procedure mobility of
the patients, along with the significant short-term reduction
in pain score and analgesic dependence, are obvious
arguments in favour of sacroplasty being the limiting factor
in patient improvement in the present series, different from
the spontaneous healing phase of conservative treatment,
which needs several months to evoke a similar effect.
Conclusion
Long-axis percutaneous sacroplasty is a suitable, mini-
mally invasive treatment option for patients who present
with sacral insufficiency fractures. Future studies with
larger patient numbers are warranted to determine any
unrecognised limitations of this therapeutic approach,
along with estimating its utility for traumatic, non-
displaced sacral injuries.
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